The Fugl-Meyer assessment (FMA) is the “Gold Standard” for the assessing individuals with brain injuries. The full assessment can take over an hour to complete. Clinicians have limited time to perform a full evaluation of their patients, the FMA is just one part of this evaluation. The lower extremity selective voluntary motor control component of the FMA (FMA-LE) is difficult for clinicians who are not experts to perform and interpret. The Selective Control Assessment of Lower Extremity (SCALE) was developed for children who have cerebral palsy (CP). The SCALE is considered reliable in the pediatric population with CP. This study aims to determine inter-rater and intra-rater reliability for the FMA-LE and the SCALE. Finally the scores on the SCALE and FMA-LE will be compared to the time it takes for stroke survivors to walk 10-meters to determine how well each measure predicts functional status.
This is an observational, prospective, cohort study with an estimated 20 participants. The study began August 5, 2018 and is expected to be completed by September 2021.
- All adults between 18 and 79 years of age who have sustained a chronic cerebrovascular accident (stroke) with known corticospinal tract damage
- At least one year after onset
- Ability to walk
- Ability to understand and follow simple instructions
- Ability to provide written, informed consent
- History of cerebellar infarct, traumatic brain injury, tumor, etc.
- Rigidity, ataxia, or other Cerebellar or Basal Ganglia signs or symptoms.
- Hospitalizations in the past 6 months
- Neurosurgical or Musculoskeletal surgery in last 12 months
- Neurological or Musculoskeletal injury within the past month
- Pain that interferes with the ability to assume side-lying position
- Medication for hypertonicity: Participants may be on medicine for abnormal tone
However, there must not be any of the following:
- Change in dosage or type of medication during the past 6 months
- Botox injection(s) within 6 months.
You may participate in this study at the University of Minnesota Minneapolis, Minnesota, United States, 55455. If you have any questions or concerns please contact Teresa Bisson, PT, DPT, NCS, ATP at 612-624-2364 or at firstname.lastname@example.org.
This study is sponsored by the University of Minnesota – Clinical and Translational Science Institute. Deborah Diaz, PT, PhD of Mary Baldwin University and Teresa Bisson, PT, DPT, NCS, ATP of the University of Minnesota – Clinical and Translational Science Institute serve as the Principal Investigators.
Clinical TrialsView All
Constraint Induced Movement Therapy Post Stroke
This is a 6 week study with three assessments to compare the effect of constraint induced movement therapy (CIMT)…
Feasibility of Better Living After Stroke Through Technology
The investigators of this study aim to evaluate the feasibility of Better Living After Stroke through Technology…
Mechanics-based Intervention to Improve Post-stroke Stability
Every year, about 15,000 American Veterans suffer from a stroke. After a stroke the ability to walk is a top goal…
Hip Hop Stroke: School-based Public Stroke Education
The program Hip Hop Stroke 2.0 helps schools fulfill NYS health education requirements. Children are also taught to…
Sensory-Motor Rehabilitation Post Stroke
The study will research early rehabilitation stroke for motor relearning, reducing ankle impairments and improving…
A Novel Approach for Brain Stimulation in Severe Stroke
The long-term goal of this clinical trial is to develop upper limb rehabilitation interventions that stroke…
Stroke Ready – Optimizing Acute Stroke Care
The goal of this clinical trial is to increase acute stroke treatment rates in Flint, Michigan through a…